Comment by eloff

Why would you expect a large gap, that's not how statistics work.

Any study of a sufficiently large population, like the phase 3 trials shouldn't vary much at all when scaled up to millions of participants.

That's assuming the error bounds are small with the clinical trials, but I think that is universally the case here.